Pharmacological inhibition of Kv1.3 channel impairs TLR3/4 activation and type I IFN response and confers protection against Listeria monocytogenes infection-Reference-Cited by-同舟云学术

Pharmacological inhibition of Kv1.3 channel impairs TLR3/4 activation and type I IFN response and confers protection against Listeria monocytogenes infection

Published:2022-03 Issue: Volume:177 Page:106112
ISSN:1043-6618
Container-title:Pharmacological Research
language:en
Short-container-title:Pharmacological Research

Author:

Zhang Xin,Lin Xiulin,Luo Hui,Zhi Yuanxing,Yi Xin,Wu Xiaoyan,Duan Wendi,Cao Ying,Pang Jianxin,Liu Shuwen,Zhou Pingzheng

Funder

Guangdong Provincial Pearl River Talents Program

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Pharmacology

Reference49 articles.

1. Regulation of type I interferon responses;Ivashkiv;Nat. Rev. Immunol.,2014

2. Pathogen recognition and innate immunity;Akira;Cell,2006

3. Pattern recognition receptors and inflammation;Takeuchi;Cell,2010

4. Regulation and function of the cGAS-STING pathway of cytosolic DNA sensing;Chen;Nat. Immunol.,2016

5. The roles of type I interferon in bacterial infection;Boxx;Cell Host Microbe,2016

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Regulatory effects of potassium channel blockers on potassium channel genes upon nervous necrosis virus infection in sevenband grouper Hyporthodus septumfasciatus;Gene;2024-01

2. The volume regulated anion channel VRAC regulates NLRP3 inflammasome by modulating itaconate efflux and mitochondria function;Pharmacological Research;2023-12

3. BmKK2, a thermostable Kv1.3 blocker from Buthus martensii Karsch (BmK) scorpion, inhibits the activation of macrophages via Kv1.3-NF-κB- NLRP3 axis;Journal of Ethnopharmacology;2023-10

4. Functional Potassium Channels in Macrophages;The Journal of Membrane Biology;2023-01-09

5. Corrigendum to “Pharmacological inhibition of Kv1.3 channel impairs TLR3/4 activation and type I IFN response and confers protection against Listeria monocytogenes infection” [Pharmacol. Res. 177 (2022) 106112];Pharmacological Research;2022-04